There is the registration on new IP coming out of the phase 2 in oral Nadolol.
Glass will be presenting results as soon as the further results are in and there will be academic interest.
Zafirlukast could hit a development milestone with toxicity testing as could inhaled Nadolol .
Partnering is of course the only way forward for any of these projects . The company is almost out of funds .
Anybody else?
What's next, page-2
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $25.69M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $5.78K | 1.445M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 12797949 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7472779 | 27 |
View Market Depth
| Last trade - 14.20pm 28/06/2024 (20 minute delay) ? |
| IVX (ASX) Chart |